Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Porphyromonas gingivalis aggravates colitis via a gut microbiota-linoleic acid metabolism-Th17/Treg cell balance axis
2024 Standout
Works of Hilde Carlier being referenced
OP05 Primary efficacy and safety of mirikizumab in moderate to severe Crohn’s Disease: results of the treat-through VIVID 1 study
2024
Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hilde Carlier | 372 | 362 | 154 | 26 | 614 | |
| Karl Baumgart | 159 | 147 | 72 | 30 | 560 | |
| R.L. Dawkins | 291 | 102 | 73 | 36 | 571 | |
| Irena Litinsky | 238 | 362 | 104 | 21 | 638 | |
| Robert E. Kalb | 530 | 110 | 80 | 17 | 665 | |
| Nufar Marcus | 248 | 75 | 34 | 42 | 593 | |
| Byron P. Croker | 252 | 113 | 38 | 24 | 628 | |
| J. A. Räsänen | 114 | 113 | 82 | 28 | 573 | |
| Kwaku Marfo | 185 | 64 | 83 | 30 | 649 | |
| Beatriz Pérez-Zafrilla | 225 | 239 | 105 | 17 | 515 | |
| Richard Hagan | 247 | 80 | 30 | 17 | 521 |
All Works
Loading papers...